These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15096367)

  • 1. Successful treatment of invasive squamous cell carcinoma using topical imiquimod.
    Hengge UR; Schaller J
    Arch Dermatol; 2004 Apr; 140(4):404-6. PubMed ID: 15096367
    [No Abstract]   [Full Text] [Related]  

  • 2. Imiquimod and squamous cell cancer.
    Hengge UR; Schaller J
    Arch Dermatol; 2005 Jun; 141(6):787-8. PubMed ID: 15967932
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of multiple lesions of Bowen's disease and squamous cell carcinoma with topical imiquimod.
    Palungwachira P; Palungwachira P; Ogawa H
    J Dermatol; 2005 Dec; 32(12):1005-9. PubMed ID: 16471467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive squamous cell carcinoma treated with imiquimod 5% cream.
    Flórez A; Feal C; de la Torre C; Cruces M
    Acta Derm Venereol; 2004; 84(3):227-8. PubMed ID: 15202841
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.
    Dirschka T; Schmitz L; Bartha Á
    Eur J Dermatol; 2016 Aug; 26(4):408-9. PubMed ID: 27097553
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream.
    Konstantopoulou M; Lord MG; Macfarlane AW
    Dermatol Online J; 2006 Mar; 12(3):10. PubMed ID: 16638424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face.
    Diluvio L; Campione E; Paternò EJ; Orlandi A; Terrinoni A; Chimenti S
    J Dermatolog Treat; 2009; 20(2):124-9. PubMed ID: 18991155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spindle cell squamous carcinoma during BRAF inhibitor therapy for advanced melanoma: an aggressive secondary neoplasm of undetermined biologic potential.
    Cohen DN; Lumbang WA; Boyd AS; Sosman JA; Zwerner JP
    JAMA Dermatol; 2014 May; 150(5):575-7. PubMed ID: 24577111
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of two invasive squamous cell carcinomas with topical 5% imiquimod cream in elderly patients.
    Tiodorovic-Zivkovic D; Zalaudek I; Longo C; De Pace B; Albertini G; Argenziano G
    Eur J Dermatol; 2012; 22(4):579-80. PubMed ID: 22652500
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of a giant squamous cell carcinoma on the dominant thumb with intralesional 5-fluorouracil.
    Reisinger DM; Cognetta AB; Pynes LT; Paredes AA; Sweeney TJ; Dolson DJ
    J Am Acad Dermatol; 2011 Jul; 65(1):219-21. PubMed ID: 21679825
    [No Abstract]   [Full Text] [Related]  

  • 11. Clearance of a thick invasive squamous cell carcinoma after multiple treatments with topical photodynamic therapy.
    Li Q; Gao T; Long HA; Ujiie H
    Photomed Laser Surg; 2010 Oct; 28(5):703-6. PubMed ID: 20961235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical imiquimod therapy for cutaneous T-cell lymphoma.
    Do JH; McLaughlin SS; Gaspari AA
    Skinmed; 2003; 2(5):316-8. PubMed ID: 14673267
    [No Abstract]   [Full Text] [Related]  

  • 13. Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma.
    Peris K; Micantonio T; Fargnoli MC; Lozzi GP; Chimenti S
    J Am Acad Dermatol; 2006 Aug; 55(2):324-7. PubMed ID: 16844522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod.
    Stockfleth E; Ulrich C; Hauschild A; Lischner S; Meyer T; Christophers E
    Eur J Dermatol; 2002; 12(6):569-72. PubMed ID: 12459530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod.
    Wolf IH; Cerroni L; Kodama K; Kerl H
    Arch Dermatol; 2005 Apr; 141(4):510-4. PubMed ID: 15837872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imiquimod - Its role in the treatment of cutaneous malignancies.
    Bubna AK
    Indian J Pharmacol; 2015; 47(4):354-9. PubMed ID: 26288465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete response of locally advanced cutaneous squamous cell carcinoma of the eyelid to topical imiquimod 3.75.
    Toso F; Tronconi MC; Cortese A; Fiorillo G; Bressan A; Costanzo A; Borroni RG
    Dermatol Ther; 2022 Nov; 35(11):e15800. PubMed ID: 36066074
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of multiple keratoacanthoma with topical imiquimod and low-dose acitretin.
    Barysch MJ; Kamarashev J; Lockwood LL; Dummer R
    J Dermatol; 2011 Apr; 38(4):390-2. PubMed ID: 21544945
    [No Abstract]   [Full Text] [Related]  

  • 20. Two cases of squamous cell carcinoma treated with topical imiquimod 5%.
    Oster-Schmidt C
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):93-5. PubMed ID: 14678542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.